title: Postpartum thyroiditis is associated with fluctuations in transforming growth factor-beta1 serum levels.
abstract: Postpartum thyroiditis (PPT) is characterized by a rapid evolution and recovery of euthyroidism. Therefore, it can represent a good model to study early cytokine fluctuations in autoimmune thyroid diseases. TGFbeta1 is an immunosuppressive cytokine, as it inhibits T and B cell proliferation, natural killer cell cytotoxic activity, and the generation of T cell cytotoxicity. The aim of this study was to assess serum concentrations of TGFbeta1 during pregnancy and to study possible serum fluctuations of this cytokine during the different phases of PPT. Thyroid biochemical pattern, antithyroid autoantibodies (ATA), and total and active TGFbeta1 (aTGFbeta1) serum concentrations were evaluated in 63 pregnant women. Thirty-four of them were ATA(+), and 29 were ATA(-). Twenty of the 34 ATA(+) women were followed in the postpartum year. Nine of these 20 women developed PPT; 11 remained euthyroid. All of the PPT women became euthyroid during the follow-up. Our results showed 1) detectable serum levels of aTGFbeta1 in 50% of ATA(+) pregnant women, suggesting that the presence of autoantibodies may characterize a favorable condition for TGFbeta1 activation; and 2) decreased total TGFbeta1 and increased aTGFbeta1 serum levels during the active phase of PPT in ATA(+) women. This seems to suggest that inflammation may be responsible for TGFbeta1 activation and autoantibody increase because of antigen release. Although further studies of women with persistent hypothyroidism after the postpartum year are needed, the possibility that the enhanced activation of TGFbeta1 may contribute to resolution of thyroid inflammation postpartum cannot be excluded.
authors.affiliation: Metabolism and Pathological Biochemistry Laboratory, Italian National Institute of Health, 00161 Rome, Italy. olivieri@iss.it
authors.forename: A
authors.initials: A
authors.lastname: Olivieri
authors.forename: S
authors.initials: S
authors.lastname: De Angelis
authors.forename: V
authors.initials: V
authors.lastname: Vaccari
authors.forename: H
authors.initials: H
authors.lastname: Valensise
authors.forename: F
authors.initials: F
authors.lastname: Magnani
authors.forename: M A
authors.initials: MA
authors.lastname: Stazi
authors.forename: R
authors.initials: R
authors.lastname: Cotichini
authors.forename: E
authors.initials: E
authors.lastname: Gilardi
authors.forename: V
authors.initials: V
authors.lastname: Cordeddu
authors.forename: M
authors.initials: M
authors.lastname: Sorcini
authors.forename: M
authors.initials: M
authors.lastname: Boirivant
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D011247:Pregnancy; D011644:Puerperal Disorders / Q000097:blood*; D013961:Thyroid Gland / Q000276:immunology; D013967:Thyroiditis, Autoimmune / Q000097:blood*; D016212:Transforming Growth Factor beta / Q000097:blood*; D053773:Transforming Growth Factor beta1
chemical_list: D001323:Autoantibodies; C508960:TGFB1 protein, human; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1